315 related articles for article (PubMed ID: 25874449)
1. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X
PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
[TBL] [Abstract][Full Text] [Related]
3. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
Hao GH; Niu XL; Gao DF; Wei J; Wang NP
Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
[TBL] [Abstract][Full Text] [Related]
4. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
Benkirane K; Amiri F; Diep QN; El Mabrouk M; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H390-7. PubMed ID: 16155101
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs.
Liu Y; Wen JK; Dong LH; Zheng B; Han M
Acta Pharmacol Sin; 2010 Jan; 31(1):10-8. PubMed ID: 20037604
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Ji Y; Liu J; Wang Z; Liu N; Gou W
Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway.
Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC
Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells.
He M; Han M; Zheng B; Shu YN; Wen JK
J Biochem; 2009 Nov; 146(5):683-91. PubMed ID: 19628677
[TBL] [Abstract][Full Text] [Related]
9. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z
Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo.
Benkirane K; Viel EC; Amiri F; Schiffrin EL
Hypertension; 2006 Jan; 47(1):102-8. PubMed ID: 16344371
[TBL] [Abstract][Full Text] [Related]
11. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiotensin II-Induced Krüppel-like factor 5 expression in vascular smooth muscle cells.
Gao D; Niu X; Ning N; Hao G
Biol Pharm Bull; 2006 Oct; 29(10):2004-8. PubMed ID: 17015941
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
Pei X; Li X; Chen H; Han Y; Fan Y
DNA Cell Biol; 2016 Aug; 35(8):426-33. PubMed ID: 27064837
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
16. cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells.
Simo-Cheyou ER; Youreva V; Srivastava AK
Can J Physiol Pharmacol; 2017 Aug; 95(8):928-937. PubMed ID: 28460186
[TBL] [Abstract][Full Text] [Related]
17. Salvianolic acid B inhibits Ang II-induced VSMC proliferation in vitro and intimal hyperplasia in vivo by downregulating miR-146a expression.
Zhao XS; Zheng B; Wen Y; Sun Y; Wen JK; Zhang XH
Phytomedicine; 2019 May; 58():152754. PubMed ID: 31009837
[TBL] [Abstract][Full Text] [Related]
18. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]